Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole for Frequent Nighttime Heartburn
NCT00701259Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lansoprazole in gastroesophageal reflux disease (GERD), sponsored by Novartis. Started Jan 2007; status: completed.
02
Drugs
lansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00701259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00701259.